Search Results - "Smitt, M."

Adjuvant T-DM1 versus trastuzumab in patients with residual invasive disease after neoadjuvant therapy for HER2-positive breast cancer: subgroup analyses from KATHERINE by Mamounas, E.P., Untch, M., Mano, M.S., Huang, C.-S., Geyer Jr, C.E., von Minckwitz, G., Wolmark, N., Pivot, X., Kuemmel, S., DiGiovanna, M.P., Kaufman, B., Kunz, G., Conlin, A.K., Alcedo, J.C., Kuehn, T., Wapnir, I., Fontana, A., Hackmann, J., Polikoff, J., Saghatchian, M., Brufsky, A., Yang, Y., Zimovjanova, M., Boulet, T., Liu, H., Tesarowski, D., Lam, L.H., Song, C., Smitt, M., Loibl, S.

“…In the KATHERINE study (NCT01772472), patients with residual invasive early breast cancer (EBC) after neoadjuvant chemotherapy (NACT) plus human epidermal…”
Get full text

The duration of fibre-optic intubation is increased by cricoid pressure. A randomised double-blind study by ARENKIEL, B., SMITT, M., OLSEN, K. S.

“…Background In some categories of patients, a rapid sequence induction using a fibre‐optic method may be indicated. The aim of the present study was to examine…”
Get full text

The importance of the lumpectomy surgical margin status in long-term results of breast conservation by Smitt, M C, Nowels, K W, Zdeblick, M J, Jeffrey, S, Carlson, R W, Stockdale, F E, Goffinet, D R

“…The impact of the surgical margin status on long-term local control rates for breast cancer in women treated with lumpectomy and radiation therapy is unclear…”
Get more information

Breast electron boost planning: comparison of CT and US by Smitt, M C, Birdwell, R L, Goffinet, D R

“…To compare computed tomography (CT) with ultrasonography (US) for depiction of the biopsy cavity. Thirty-two consecutive patients who underwent radiation…”
Get more information

Beyond hydrogeologic evidence: challenging the current assumptions about salinity processes in the Corangamite region, Australia by Dahlhaus, P. G, Cox, J. W, Simmons, C. T, Smitt, C. M

“…In keeping with the standard scientific methods, investigations of salinity processes focus on the collection and interpretation of contemporary scientific…”
Get full text

Radiation therapy for benign disease of the orbit by Smitt, Melanie C., Donaldson, Sarah S.

“…Benign diseases of the orbit can cause significant impairment of visual function through direct effects on the eye or supporting orbital tissues. Persistent…”
Get full text

Radiotherapy is successful treatment for orbital lymphoma by Smitt, M C, Donaldson, S S

“…To describe the clinical presentation, treatment technique, outcome and complications in a large single institutional experience using radiotherapy for…”
Get more information

Breast-conserving radiation therapy: potential of inverse planning with intensity modulation by Smitt, M C, Li, S D, Shostak, C A, Chang, W, Boyer, A L

“…To evaluate inverse planning with beam-intensity modulation in breast-conserving radiation therapy. A prototype inverse treatment-planning system was used in…”
Get more information

Utility of three-dimensional planning for axillary node coverage with breast-conserving radiation therapy: early experience by Smitt, M C, Goffinet, D R

“…To examine the dosimetric axillary nodal coverage with standard tangential breast radiation fields and determine the utility of three-dimensional treatment…”
Get more information

Is Diagnostic Review of Radiotherapy-Planning CT Scans Important in the Conformal Therapy Era? by Smitt, Melanie C, Mehta, Vivek K

“…Detailed CT scans are often acquired during the radiotherapy planning process. This study was performed to determine the incidence of important benign and…”
Get full text

8519 A phase 2, randomized trial (CONCERT-1) of chemoradiotherapy with or without panitumumab in patients (pts) with unresected, locally advanced squamous cell carcinoma of the head and neck (SCCHN): Interim pooled safety analysis by Fortin, A, Cmelak, A, Mesía, R, Minn, H, Chan, A.T.C, Yunes, A.C, Merlano, M.C, Singh, S, Smitt, M, Henke, M

Get full text

7110 Efficacy and safety of AMG 102 in patients with advanced renal cell carcinoma (RCC) by Kabbinavar, F, Garcia, J.A, Stadler, W.M, Gil, T, Jonasch, E, Tagawa, S.T, Smitt, M, Yang, X, Oliner, K, Schöffski, P

Get full text

8516 A phase 2 randomized trial of radiotherapy (RT) plus panitumumab compared to chemoradiotherapy in patients with unresected, locally advanced squamous cell carcinoma of the head and neck (SCCHN): interim pooled safety analysis by Giralt, J, Trigo, J.M, Nuyts, S, Ozsahin, M, Markowitz, A.B, Daisne, J, Skladowski, K, Lonchay, C, Holeckova, P, Smitt, M

Get full text

The results of radical prostatectomy at a community hospital during the prostate specific antigen era by Smitt, Melanie C., Heltzel, Marianne

“…BACKGROUND The use of radical prostatectomy in the treatment of prostate cancer has increased with the advent of prostate specific antigen (PSA) screening. Few…”
Get full text

Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer by von Minckwitz, Gunter, Huang, Chiun-Sheng, Mano, Max S, Loibl, Sibylle, Mamounas, Eleftherios P, Untch, Michael, Wolmark, Norman, Rastogi, Priya, Schneeweiss, Andreas, Redondo, Andres, Fischer, Hans H, Jacot, William, Conlin, Alison K, Arce-Salinas, Claudia, Wapnir, Irene L, Jackisch, Christian, DiGiovanna, Michael P, Fasching, Peter A, Crown, John P, Wülfing, Pia, Shao, Zhimin, Rota Caremoli, Elena, Wu, Haiyan, Lam, Lisa H, Tesarowski, David, Smitt, Melanie, Douthwaite, Hannah, Singel, Stina M, Geyer, Charles E

“…Residual cancer after induction therapy for HER2-positive breast cancer is associated with a worse prognosis than no residual cancer. In a randomized trial,…”
Get full text

Results of the 1988-1989 Patterns of Care Study process survey for Hodgkin's disease by Smitt, M C, Stouffer, N, Owen, J B, Hoppe, R T, Hanks, G E

“…To document national standards of care for patients receiving radiotherapy as part of curative treatment for Hodgkin's disease. A national survey was conducted…”
Get more information

A phase II study evaluating the efficacy and safety of AMG 102 (rilotumumab) in patients with recurrent glioblastoma by Wen, Patrick Y., Schiff, David, Cloughesy, Timothy F., Raizer, Jeffrey J., Laterra, John, Smitt, Melanie, Wolf, Michael, Oliner, Kelly S., Anderson, Abraham, Zhu, Min, Loh, Elwyn, Reardon, David A.

“…This phase II study evaluated the efficacy and safety of AMG 102 (rilotumumab), a fully human monoclonal antibody against hepatocyte growth factor/scatter…”
Get full text

Radiotherapy for carcinoma-in-situ of the glottic larynx by Smitt, M C, Goffinet, D R

“…To describe the long-term results of radiotherapy as treatment for carcinoma-in-situ of the glottic larynx. Twenty-nine patients with a histologic diagnosis of…”
Get more information

Women's use of resources in decision-making for early-stage breast cancer: results of a community-based survey by Smitt, M C, Heltzel, M

“…The majority of women with stage I/II breast cancer may choose between mastectomy and breast-conserving therapy (BCT). A survey was designed to examine the…”
Get full text

Abstract P4-21-26: Population pharmacokinetics (PK) and exposure-response (E-R) analysis of trastuzumab emtansine (T-DM1) in patients with HER2+ metastatic breast cancer (MBC) who have received at least two prior regimens of HER2-directed therapy by Chen, S-C, Polhamus, D, Riggs, M, French, J, Wang, X, Smitt, M, Hoersch, S, Strasak, A, Chernyukhin, N, Quartino, A, Jin, J, Girish, S, Li, C

“…Abstract Background: TH3RESA was a Phase III randomized study to evaluate the efficacy and safety of trastuzumab emtansine (T-DM1) compared to treatment of…”
Get full text